Compounds > lysine
Page last updated: 2024-08-17

lysine and carmustine

lysine has been researched along with carmustine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Crone, TM; Kanugula, S; Loktionova, NA; Pegg, AE; Xu-Welliver, M1
Belyavsky, AV; Grinenko, TS; Krasnov, VP; Levit, GL; Rozov, FN1
Balabanov, S; Bokemeyer, C; Braig, M; Hagel, C; Hauber, J; Lamszus, K; Pällmann, N; Preukschas, M; Schulte, A; Sievert, H; Weber, K1

Other Studies

4 other study(ies) available for lysine and carmustine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Conserved residue lysine165 is essential for the ability of O6-alkylguanine-DNA alkyltransferase to react with O6-benzylguanine.
    The Biochemical journal, 2000, Apr-15, Volume: 347, Issue:Pt 2

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Antineoplastic Agents; Binding Sites; Carmustine; CHO Cells; Conserved Sequence; Cricetinae; DNA; DNA Repair; Drug Resistance; Escherichia coli; Guanine; Humans; Lysine; Methylnitronitrosoguanidine; Molecular Sequence Data; Mutation; O(6)-Methylguanine-DNA Methyltransferase; Protein Binding; Sequence Alignment; Transfection

2000
Selection of genetically modified hematopoietic cells in vitro and in vivo using alkylating agent lysomustine.
    Analytical biochemistry, 2010, Sep-15, Volume: 404, Issue:2

    Topics: Alkylating Agents; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carmustine; Cell Line, Tumor; Female; Genetic Vectors; Humans; Lentivirus; Lysine; Mice; Mice, Inbred C57BL; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Transfection

2010
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Apoptosis; Carmustine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Dacarbazine; Eukaryotic Translation Initiation Factor 5A; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Guanine; Humans; Lysine; Male; Mixed Function Oxygenases; Molecular Targeted Therapy; Neoplasm Grading; Oxidoreductases Acting on CH-NH Group Donors; Peptide Initiation Factors; RNA-Binding Proteins; Temozolomide

2012